SLN

Silence Therapeutics plc

Phase 1 AI-extracted

Zerlasiran

High Lp(a)

Date

TBD

Phase 1 readout · Date TBD estimated

What's at stake Phase 1 trial results for Zerlasiran in High Lp(a) are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 8-K verified 15h ago

“Preclinical data Preclinical data SLN365 HoFH Zerlasiran High Lp(a) IND enabling studies (potential filing in 1H 2027)”

Add to calendar Post on X Reddit

Provenance